Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOLODODEKIN ALFA: 564 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
564
Total FAERS Reports
61 (10.8%)
Deaths Reported
228
Hospitalizations
564
As Primary/Secondary Suspect
78
Life-Threatening
8
Disabilities

First Report: 20170401 · Latest Report: 20250920

What Are the Most Common TOLODODEKIN ALFA Side Effects?

#1 Most Reported
Off label use
81 reports (14.4%)
#2 Most Reported
Neutropenia
59 reports (10.5%)
#3 Most Reported
Plasma cell myeloma
52 reports (9.2%)

All TOLODODEKIN ALFA Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Off label use 81 14.4% 12 17
Neutropenia 59 10.5% 6 11
Plasma cell myeloma 52 9.2% 11 12
Thrombocytopenia 48 8.5% 5 10
Anaemia 44 7.8% 7 17
Drug ineffective 44 7.8% 2 8
Infusion related reaction 42 7.5% 3 14
Pneumonia 37 6.6% 8 8
Pyrexia 34 6.0% 4 22
Febrile neutropenia 31 5.5% 2 17
Infection 31 5.5% 9 2
Covid-19 30 5.3% 15 11
Myelosuppression 26 4.6% 0 14
Acute kidney injury 24 4.3% 1 18
Disease progression 24 4.3% 3 6
Neuropathy peripheral 24 4.3% 5 3
Diarrhoea 19 3.4% 3 8
Cough 17 3.0% 2 5
Therapeutic product effect incomplete 17 3.0% 3 3
Drug ineffective for unapproved indication 16 2.8% 1 1

Who Reports TOLODODEKIN ALFA Side Effects? Age & Gender Data

Gender: 46.2% female, 53.8% male. Average age: 65.5 years. Most reports from: EU. View detailed demographics →

Is TOLODODEKIN ALFA Getting Safer? Reports by Year

YearReportsDeathsHosp.
2017 1 0 0
2018 1 0 0
2019 5 0 2
2020 4 1 2
2021 8 0 4
2022 15 0 2
2023 29 4 19
2024 32 6 26
2025 168 8 122

View full timeline →

What Is TOLODODEKIN ALFA Used For?

IndicationReports
Plasma cell myeloma 375
Plasma cell myeloma refractory 46
Product used for unknown indication 33
Prophylaxis against transplant rejection 12
Primary amyloidosis 11
T-cell lymphoma 8
Amyloidosis 7
Immunosuppressant drug therapy 6
Plasma cell leukaemia 6
Poems syndrome 5

TOLODODEKIN ALFA vs Alternatives: Which Is Safer?

TOLODODEKIN ALFA vs TOLTERODINE TOLODODEKIN ALFA vs TOLVAPTAN TOLODODEKIN ALFA vs TOPAMAX TOLODODEKIN ALFA vs TOPIRAMATE TOLODODEKIN ALFA vs TOPOTECAN TOLODODEKIN ALFA vs TOPOTECAN\TOPOTECAN TOLODODEKIN ALFA vs TOPROL TOLODODEKIN ALFA vs TOREMIFENE TOLODODEKIN ALFA vs TORIPALIMAB TOLODODEKIN ALFA vs TORSEMIDE

Official FDA Label for TOLODODEKIN ALFA

Official prescribing information from the FDA-approved drug label.